Trademark: 90021844
Word
+RFID
Status
Registered
Status Code
700
Status Date
Tuesday, December 5, 2023
Serial Number
90021844
Registration Number
7236831
Registration Date
Tuesday, December 5, 2023
Mark Type
4000
Filing Date
Friday, June 26, 2020
Published for Opposition
Tuesday, May 25, 2021

Trademark Owner History
Fresenius Kabi USA, LLC - Original Registrant

Classifications
5 Radio frequency identification tagged pharmaceutical products, namely, anesthetics, analgesics, anti-infectives, anti-emetics; Radio frequency identification tagged pharmaceutical products, namely, radiological, magnetic resonance imaging, and ultrasound contrast agents for diagnostic and imaging procedures for medical purposes; Radio frequency identification tagged pharmaceutical products, namely, sedatives; Radio frequency identification tagged pharmaceutical products, namely, cardiovascular pharmaceuticals; Radio frequency identification tagged pharmaceutical products, namely, oncology pharmaceuticals being pharmaceutical preparations and substances for the treatment of cancer and for the treatment of tumors; Radio frequency identification tagged pharmaceutical products, namely, critical care pharmaceuticals being essential to the management of critically and chronically ill patients, being anticoagulants, anti-inflammatory pharmaceuticals, hormones, electrolyte injection solutions for medical use, and pharmaceuticals acting on the central nervous system; Radio frequency identification tagged pharmaceutical products, namely, diluents for medical purposes in the nature of intravenous bags sold filled with pharmaceutical preparations being sodium chloride injection solutions, dextrose injection solutions, lactated ringer's injection solutions, and water for injection
"RFID"

Trademark Events
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Dec 5, 2023
Registered-Principal Register
Nov 1, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 31, 2023
Allowed Principal Register - Sou Accepted
Jul 10, 2023
Statement Of Use Processing Complete
Jun 12, 2023
Use Amendment Filed
Jul 10, 2023
Case Assigned To Intent To Use Paralegal
Jun 12, 2023
Teas Statement Of Use Received
Dec 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2022
Sou Extension 3 Granted
Nov 29, 2022
Sou Extension 3 Filed
Nov 29, 2022
Sou Teas Extension Received
Jun 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2022
Sou Extension 2 Granted
Jun 27, 2022
Sou Extension 2 Filed
Jun 27, 2022
Sou Teas Extension Received
Jan 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 13, 2022
Sou Extension 1 Granted
Jan 13, 2022
Sou Extension 1 Filed
Jan 13, 2022
Sou Teas Extension Received
Jul 20, 2021
Noa E-Mailed - Sou Required From Applicant
May 25, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Published For Opposition
May 5, 2021
Notification Of Notice Of Publication E-Mailed
Apr 15, 2021
Approved For Pub - Principal Register
Mar 2, 2021
Teas/Email Correspondence Entered
Mar 2, 2021
Correspondence Received In Law Office
Mar 2, 2021
Teas Request For Reconsideration Received
Feb 15, 2021
Notification Of Final Refusal Emailed
Feb 15, 2021
Final Refusal E-Mailed
Feb 15, 2021
Final Refusal Written
Jan 13, 2021
Teas/Email Correspondence Entered
Jan 13, 2021
Correspondence Received In Law Office
Jan 13, 2021
Teas Response To Office Action Received
Dec 15, 2020
Teas/Email Correspondence Entered
Dec 15, 2020
Correspondence Received In Law Office
Dec 15, 2020
Teas Response To Office Action Received
Oct 9, 2020
Notification Of Non-Final Action E-Mailed
Oct 9, 2020
Non-Final Action E-Mailed
Oct 9, 2020
Non-Final Action Written
Sep 29, 2020
Assigned To Examiner
Jul 23, 2020
New Application Office Supplied Data Entered
Jun 30, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24